These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 3252295)
1. [The effect of atropine on bronchial obstruction in asthma patients]. Cvitanović S; Tocilj J Plucne Bolesti; 1988; 40(3-4):146-8. PubMed ID: 3252295 [No Abstract] [Full Text] [Related]
2. [Evaluation of bronchial tree function by the flow-volume test in bronchial asthma patients]. Doronina IuV; Vinitskaia RS; Timofeeva VA Sov Med; 1984; (5):44-7. PubMed ID: 6463722 [No Abstract] [Full Text] [Related]
3. The effect of vagolytic drugs on airway obstruction in patients with bronchial asthma. Firstater E; Mizrachi E; Topilsky M Ann Allergy; 1981 Jun; 46(6):332-5. PubMed ID: 6454371 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of exercise-induced bronchospasm by atropine. Tinkelman DG; Cavanaugh MJ; Cooper DM Am Rev Respir Dis; 1976 Jul; 114(1):87-94. PubMed ID: 779554 [TBL] [Abstract][Full Text] [Related]
5. Successive effects of a vagolitic and a betadrenergic in the differential diagnosis of nonimmunologic and allergic asthma. Mathov E; Jares DM Allergol Immunopathol (Madr); 1984; 12(4):293-302. PubMed ID: 6239524 [TBL] [Abstract][Full Text] [Related]
7. Inhaled atropine in asthma. Snow RM; Miller WC; Blair HT; Rice DL Ann Allergy; 1979 May; 42(5):286-9. PubMed ID: 453644 [TBL] [Abstract][Full Text] [Related]
8. Bronchial asthma without increased airway reactivity. Stănescu DC; Frans A Eur J Respir Dis; 1982 Jan; 63(1):5-12. PubMed ID: 7067756 [TBL] [Abstract][Full Text] [Related]
9. [Magnesium salts in the treatment of bronchial asthma]. Radomyski A; Araszkiewicz Z Pneumonol Alergol Pol; 1992; 60(1-2):67-70. PubMed ID: 1290984 [No Abstract] [Full Text] [Related]
10. The value of atropine in the documentation of reversible airways obstruction. Brady RE; Easton JG Ann Allergy; 1979 Apr; 42(4):211-7. PubMed ID: 373517 [TBL] [Abstract][Full Text] [Related]
11. Pulmonary function in symptom-free asthmatics. Yaacob I; Mohammad M Singapore Med J; 1993 Dec; 34(6):522-3. PubMed ID: 8153715 [TBL] [Abstract][Full Text] [Related]
15. The physiologic effect of an intravenous glucocorticoid in bronchial asthma. Klaustermeyer WB; Hale FC Ann Allergy; 1976 Aug; 37(2):80-6. PubMed ID: 788558 [TBL] [Abstract][Full Text] [Related]
16. Respiratory symptoms and pulmonary functional changes in patients with irritable bowel syndrome. Yazar A; Atis S; Konca K; Pata C; Akbay E; Calikoglu M; Hafta A Am J Gastroenterol; 2001 May; 96(5):1511-6. PubMed ID: 11374691 [TBL] [Abstract][Full Text] [Related]
17. Bronchial response to hyperventilation of dry air at room temperature in normals and asthmatics. Denjean A; Matran R; Mathieu M; Cerrina J; Duroux P; Lockhart A Bull Eur Physiopathol Respir; 1983; 19(5):477-82. PubMed ID: 6640167 [TBL] [Abstract][Full Text] [Related]
18. [Nonspecific bronchial hyperreactivity after long-term use of a beta 2 agonist]. Krasnowska M; Liebhart E; Małolepszy J Pneumonol Pol; 1988 Nov; 56(11):501-6. PubMed ID: 3252190 [No Abstract] [Full Text] [Related]
19. [Maximal expiratory flow (peak flow) in the evaluation of bronchial obstruction]. Cukier A; Tsanaclis A; Pereira JR; Croce J; Romeiro Neto MM; Vargas FS Rev Hosp Clin Fac Med Sao Paulo; 1980 Oct; 35(5):236-8. PubMed ID: 6453417 [No Abstract] [Full Text] [Related]
20. [Maximum expiratory flow rate (peak flow) in healthy persons and patients with bronchial asthma]. Vargas FS; Cukier A; Terra Filho M; Croce J; Romeiro Neto MM Allergol Immunopathol (Madr); 1982; 10(2):91-4. PubMed ID: 6213139 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]